AI Program Could Aid Decision-Making in Medical Imaging
By HospiMedica International staff writers Posted on 24 Sep 2018 |

Image: The Explainable Artificial Intelligence (XAI) program can help with decision-making in various medical fields (Photo courtesy of Raytheon BBN Technologies).
Researchers are developing a first of its kind neural network that explains itself and could help with decision-making in the medical field, among others. Raytheon BBN Technologies (Cambridge, MA, USA) is developing the neural network under the Defense Research Project Agency's (DARPA) Explainable Artificial Intelligence program (XAI). The aim of the XAI program is to create a suite of machine learning techniques, which produce more explainable models while maintaining a high level of performance. It also aims to help human users understand, appropriately trust and effectively manage the emerging generation of artificially intelligent partners.
The Explainable Question Answering System (EQUAS) by Raytheon BBN will allow Artificial Intelligence (AI) programs to 'show their work,' increasing the human user's confidence in the machine's suggestions. EQUAS will show users which data mattered most in the AI decision-making process. Using a graphical interface, users can explore the system's recommendations and see why it chose one answer over another. Although the technology is still in its early phases of development, it has the potential to be used for a wide-range of applications. As the system is enhanced, EQUAS will be able to monitor itself and share factors that limit its ability to make reliable recommendations. This self-monitoring capability will help developers refine AI systems, allowing them to inject additional data or change how data is processed.
"A fully developed system like EQUAS could help with decision-making not only in DoD operations, but in a range of other applications like campus security, industrial operations and the medical field," said Bill Ferguson, lead scientist and EQUAS principal investigator at Raytheon BBN. "Say a doctor has an x-ray image of a lung and her AI system says that its cancer. She asks why and the system highlights what it thinks are suspicious shadows, which she had previously disregarded as artifacts of the X-ray process. Now the doctor can make the call – to diagnose, investigate further, or, if she still thinks the system is in error, to let it go."
Related Links:
Raytheon BBN Technologies
The Explainable Question Answering System (EQUAS) by Raytheon BBN will allow Artificial Intelligence (AI) programs to 'show their work,' increasing the human user's confidence in the machine's suggestions. EQUAS will show users which data mattered most in the AI decision-making process. Using a graphical interface, users can explore the system's recommendations and see why it chose one answer over another. Although the technology is still in its early phases of development, it has the potential to be used for a wide-range of applications. As the system is enhanced, EQUAS will be able to monitor itself and share factors that limit its ability to make reliable recommendations. This self-monitoring capability will help developers refine AI systems, allowing them to inject additional data or change how data is processed.
"A fully developed system like EQUAS could help with decision-making not only in DoD operations, but in a range of other applications like campus security, industrial operations and the medical field," said Bill Ferguson, lead scientist and EQUAS principal investigator at Raytheon BBN. "Say a doctor has an x-ray image of a lung and her AI system says that its cancer. She asks why and the system highlights what it thinks are suspicious shadows, which she had previously disregarded as artifacts of the X-ray process. Now the doctor can make the call – to diagnose, investigate further, or, if she still thinks the system is in error, to let it go."
Related Links:
Raytheon BBN Technologies
Latest AI News
Channels
Critical Care
view channel
Implantable Device Could Save Diabetes Patients from Dangerously Low Blood Sugar
For individuals with Type 1 diabetes, hypoglycemia (low blood sugar) presents a life-threatening threat, particularly when glucose levels drop too low, which can result in seizures, coma, or even death.... Read more
New Prostate Screening Device Could Replace Traditional Examination Method
Prostate cancer is a leading health concern, with one in seven men being diagnosed with the disease. Early detection is critical for improving patient outcomes, but traditional diagnostic methods, such... Read moreSurgical Techniques
view channel
Fluorescent Imaging Agent ‘Lights Up’ Nerves for Better Visualization During Surgery
Surgical nerve injury is a significant concern in head and neck surgeries, where nerves are at risk of being inadvertently damaged during procedures. Such injuries can lead to complications that may impact... Read more
LED-Based Imaging System Could Transform Cancer Detection in Endoscopy
Gastrointestinal cancers remain one of the most common and challenging forms of cancer to diagnose accurately. Despite the widespread use of endoscopy for screening and diagnosis, the procedure still misses... Read morePatient Care
view channel
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
VR Training Tool Combats Contamination of Portable Medical Equipment
Healthcare-associated infections (HAIs) impact one in every 31 patients, cause nearly 100,000 deaths each year, and cost USD 28.4 billion in direct medical expenses. Notably, up to 75% of these infections... Read more
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read moreHealth IT
view channel
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Smartwatches Could Detect Congestive Heart Failure
Diagnosing congestive heart failure (CHF) typically requires expensive and time-consuming imaging techniques like echocardiography, also known as cardiac ultrasound. Previously, detecting CHF by analyzing... Read moreBusiness
view channel
Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies
A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more